Matthias Tschöp receives honorary doctorate from the University of Leipzig

On 13 February, Prof. Matthias Tschöp, Director of the Institute for Diabetes and Obesity at the Helmholtz Zentrum München, was awarded an honorary doctorate by the University of Leipzig. "He is undoubtedly one of the most outstanding scientific personalities worldwide in the field of metabolic research and endocrinology,“ noted Prof. Michael Stumvoll, Dean of the Medical Faculty.

Matthias Tschöp receives honorary doctorate from the University of Leipzig

Prof. Dr. Beate Schücking (Director of the University of Leipzig), Prof. Dr. Matthias Tschöp, Prof. Dr. Michael Stumvoll (Dean of the Medical Faculty) and Prof. Dr. Ingo Bechmann (Laudator and Director of the Institute of Anatomy at the Medical Faculty of the University of Leipzig)

Prof. Matthias Tschöp’s research activities focus on translational research to find new precision medicines for the prevention and treatment of diabetes and obesity. He pioneered the mechanistic basis for gut-brain communication and its role in the systemic control of metabolism.

"Matthias Tschöp is one of the few outstanding scientists worldwide in the fields of endocrinology and diabetology who have made truly groundbreaking discoveries: a hormone – ghrelin – and an entirely new treatment principle that lowers blood sugar and at the same time suppresses appetite. It will soon be available for clinical use in the treatment of diabetes and obesity, and in the coming years will considerably expand our medication-based treatment options. It is a great honor for us to retain him in our faculty as an honorary doctor as this will enable us to further intensify existing cooperation in both research and teaching in our focal research area, namely lifestyle diseases,” Prof. Michael Stumvoll said.

"The University of Leipzig was one of the first scientific institutions in Germany to realize that the overriding majority of common diseases today are triggered or exacerbated by the rapidly growing obesity epidemic. As a diabetes researcher, it is therefore a very special honor to receive this award from a university that not only has the vision to recognize this problem, but has consistently set priorities and today leads research on obesity at an international level,“  Tschöp said. The presentation speech at the award ceremony, held in the Old Senate Room at the University of Leipzig, was given by Prof. Dr. Ingo Bechmann, Director of the Institute of Anatomy at the Medical Faculty of the University of Leipzig.

Matthias Tschöp was born in Munich in 1967. After obtaining his MD and PhD degrees from the Ludwig-Maximilians-University in Munich, he accepted a postdoctoral position at the Eli Lilly Research Laboratories in Indianapolis and was subsequently appointed Senior Scientist, Dept. of Pharmacology, German Institute of Human Nutrition (DlfE) in Potsdam. From 2003 to 2011 he was Professor of Endocrinology at the University of Cincinnati’s Metabolic Diseases Institute and Research Director at the Cincinnati Diabetes & Obesity Center. Since 2011 Tschöp has held the Chair of Metabolic Diseases at the Technical University of Munich (TUM) and headed the Institute of Diabetes and Obesity at the Helmholtz Zentrum München. In 2011 he became the first German physician to receive Germany’s prestigious research prize, the Alexander von Humboldt Professorship and in 2013 he was elected a member of the Leopoldina, the German National Academy of Sciences. In addition, he has received numerous high-ranking accolades, including Outstanding Scientific Achievement Award of the Obesity Society (TOS, 2007), the American Diabetes Association (ADA, 2011) and the Endocrine Society (2017).